Geneva, March 23 -- International Clinical Trials Registry received information related to the study (ACTRN12626000285358) titled 'Precision Dosing of Anti-Cancer Medicines for patients undergoing Oncology, Blood Transplant and Cellular Therapies' on March 5.
Study Type: Observational
Study Design:
Duration: Longitudinal
Selection: Defined population
Timing: Prospective
Primary Sponsor: The Children's Hospital at Westmead
Condition:
acute leukaemias
Inborn errors of metabolism
solid tumours
acute leukaemias
Inborn errors of metabolism
solid tumours
Cancer - Children's - Leukaemia & Lymphoma
Human Genetics and Inherited Disorders - Other human genetics and inherited disorders
Cancer - Children's - Brain
Intervention:
This is a pr...